Bhattacharya S K
National Institute of Cholera and Enteric Diseases, P33, CIT Road, Scheme XM, Beliagata, Kolkata 700010, West Bengal, India.
Natl Med J India. 2003;16 Suppl 2:15-9.
Acute diarrhoeal diseases constitute one of the major health problems among young children in India. It was estimated in 1978 that 1.5 million children under the age of 5 years die due to diarrhoea every year, which declined to 0.6-0.7 million in the estimate revised in 1992. A similar declining trend has also been noted in hospitalized cases in Calcutta (present Kolkata) during 1980-95 as well as from other parts of India. Even today, cholera epidemics occur regularly in India. The cholera epidemic caused by a novel strain of Vibrio cholerae, designated as V. cholerae 0139 Bengal in 1992 and multidrug-resistant shigellosis in eastern India in 1984 are matters of grave concern. The launching of the National Diarrhoeal Diseases Control Programme (CDD) in 1978, based on a three-tier approach, is of great importance. The rate of use of oral rehydration salt (ORS) solution and oral rehydration therapy (ORT) remain suboptimal in India. In spite of the launching of the 'Ganga Action Plan' and the 'National River Action Plan', India faces a major problem of diarrhoeal diseases. Lack of safe water supply, poor environmental sanitation, improper disposal of human excreta and poor personal hygiene help to perpetuate and spread diarrhoeal diseases in India. Since diarrhoeal diseases are caused by 20-25 pathogens, vaccination, though an attractive disease prevention strategy, is not feasible. However, as the majority of childhood diarrhoeas are caused by V. cholerae, Shigellae dysenteriae type 1, rotavirus and enterotoxigenic Escherichia coli (E. coli) which have a high morbidity and mortality, vaccines against these organisms are essential for the control of epidemics. A strong political will with appropriate budgetary allocation is essential for the control of childhood diarrhoeal diseases in India, a formidable task in a country with a population of over 1 billion.
急性腹泻病是印度幼儿面临的主要健康问题之一。据1978年估计,每年有150万5岁以下儿童死于腹泻,在1992年修订的估计中这一数字降至60万至70万。1980 - 1995年期间,加尔各答(现加尔各答)以及印度其他地区的住院病例也呈现出类似的下降趋势。即使在今天,印度仍定期发生霍乱疫情。1992年由一种新型霍乱弧菌菌株(称为霍乱弧菌0139孟加拉型)引起的霍乱疫情以及1984年印度东部的多重耐药志贺菌病令人严重关切。1978年基于三层方法启动的国家腹泻病控制计划(CDD)至关重要。在印度,口服补液盐(ORS)溶液和口服补液疗法(ORT)的使用率仍然不理想。尽管启动了“恒河行动计划”和“国家河流行动计划”,但印度仍面临腹泻病的重大问题。安全供水不足、环境卫生差、人类排泄物处理不当以及个人卫生习惯不良,使得腹泻病在印度持续存在并传播。由于腹泻病由20 - 25种病原体引起,疫苗接种虽然是一种有吸引力的疾病预防策略,但并不可行。然而,由于大多数儿童腹泻是由霍乱弧菌、痢疾志贺菌1型、轮状病毒和产肠毒素大肠杆菌(E. coli)引起的,这些病原体具有高发病率和死亡率,针对这些病原体的疫苗对于控制疫情至关重要。在印度这个拥有超过10亿人口的国家,要控制儿童腹泻病,强大的政治意愿和适当的预算分配至关重要,这是一项艰巨的任务。